Featured Research

from universities, journals, and other organizations

Discoveries Point to More Powerful Cancer Treatments, Fewer Side Effects

Date:
February 27, 2014
Source:
Rutgers Biomedical and Health Sciences
Summary:
What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? Newly published research adds to evidence that inhibition of eEF2K would enhance the benefits chemo and radiation therapy by sharply reducing death of healthy cells and accompanying side effects. Side effects such as heart damage, nausea and hair loss occur when cancer therapy kills healthy cells along with the malignant cells that are being targeted. But the lead researcher explains that if a way could be found to protect those healthy cells, then doses of chemo and radiation could actually be increased, “killing all the cancer cells and the patient would be cured. We also could start treating cancers that now can’t be cured because the most effective doses are too toxic to normal tissues.”

A mechanism that Alexey Ryazanov is developing could make cancer therapy both more effective and less toxic.
Credit: Andrew Hanenberg

What if there were a way to make chemotherapy and radiation more effective as cancer treatments than they are today, while also getting rid of debilitating side effects that patients dread? A new study led by Alexey Ryazanov, a professor of pharmacology at Rutgers Robert Wood Johnson Medical School and member of the Rutgers Cancer Institute of New Jersey, suggests the day that happens could be getting closer.

Related Articles


Side effects such as heart damage, nausea and hair loss occur when cancer therapy kills healthy cells along with the malignant cells that are being targeted. It is a medical form of collateral damage. But Ryazanov explains that if a way could be found to protect those healthy cells, then doses of chemo and radiation could actually be increased, “killing all the cancer cells and the patient would be cured. We also could start treating cancers that now can’t be cured because the most effective doses are too toxic to normal tissues.”

The key to Ryazanov’s vision of cancer treatment is addition by subtraction – specifically elimination of eEF2K – an enzyme that influences the rates at which proteins are created in the human body. Ryazanov first identified eEF2K more than a quarter century ago, and since then, bit by bit, he and other scientists have uncovered many complicated processes for which that enzyme is responsible.

Ryazanov’s latest findings, published in the journal Developmental Cell, demonstrate that the presence of eEF2K weakens healthy cells. His evidence is the enzyme’s involvement in a process where defective cells involved in reproduction are degraded – and ultimately destroyed – as a way to preserve genetic quality from one generation to the next.

There is eEF2K in every cell in the body, and Ryazanov says the enzyme’s presence tends to leave cells less robust than they otherwise would be. According to Ryazanov, it is that added weakness that leaves healthy cells vulnerable to being poisoned by chemo and radiation.

Ryazanov says removing the enzyme would make those healthy cells stronger, to the point where they would survive cancer therapy. That, in turn, would eliminate the side effects.

How would healthy cells survive cancer treatment while malignant cells would not? Ryazanov explains that tumors grow and cancer spreads when malignant cells divide and duplicate. Chemo and radiation are specifically designed to block cell division, and Ryazanov says removing the enzyme eEF2K actually makes the cancer cells more vulnerable to the treatment. By contrast, as long as healthy cells are strong enough to resist being poisoned, the cancer therapies won’t hurt them.

In 2008, Ryazanov founded Longevica Pharmaceuticals, a company whose mission is to perfect medications designed to eliminate the enzyme and improve the performance of chemo and radiation. Animal testing is already underway, and Ryazanov hopes that his new findings will speed the day when medications that pass those tests can be tried in people. He even predicts that taking such a drug may be as easy as swallowing a pill.

Ryazanov says there is a nice logic to the research and drug development that have become his life’s work – because the cancer therapies he wants to enhance already exist and are known to work. Making chemo and radiation less toxic, he says, can make those therapies dramatically more effective in the relatively near future, while other cutting-edge approaches to cancer treatment might need far more time to prove their ultimate worth.


Story Source:

The above story is based on materials provided by Rutgers Biomedical and Health Sciences. The original article was written by Rob Forman. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hsueh-Ping Chu, Yi Liao, JamesS. Novak, Zhixian Hu, JasonJ. Merkin, Yuriy Shymkiv, BartP. Braeckman, MaximV. Dorovkov, Alexandra Nguyen, PeterM. Clifford, RobertG. Nagele, DavidE. Harrison, RonaldE. Ellis, AlexeyG. Ryazanov. Germline Quality Control: eEF2K Stands Guard to Eliminate Defective Oocytes. Developmental Cell, 2014; DOI: 10.1016/j.devcel.2014.01.027

Cite This Page:

Rutgers Biomedical and Health Sciences. "Discoveries Point to More Powerful Cancer Treatments, Fewer Side Effects." ScienceDaily. ScienceDaily, 27 February 2014. <www.sciencedaily.com/releases/2014/02/140227125159.htm>.
Rutgers Biomedical and Health Sciences. (2014, February 27). Discoveries Point to More Powerful Cancer Treatments, Fewer Side Effects. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2014/02/140227125159.htm
Rutgers Biomedical and Health Sciences. "Discoveries Point to More Powerful Cancer Treatments, Fewer Side Effects." ScienceDaily. www.sciencedaily.com/releases/2014/02/140227125159.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Breakfast Debate: To Eat Or Not To Eat?

Breakfast Debate: To Eat Or Not To Eat?

Newsy (Oct. 23, 2014) Conflicting studies published in the same week re-ignited the debate over whether we should be eating breakfast. Video provided by Newsy
Powered by NewsLook.com
Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Despite Rising Death Toll, Many Survive Ebola

Despite Rising Death Toll, Many Survive Ebola

AP (Oct. 23, 2014) The family of a Dallas nurse infected with Ebola in the US says doctors can no longer detect the virus in her. Despite the mounting death toll in West Africa, there are survivors there too. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins